1Veikkola T, Karkkainen M, Claesson-Welsh L, et al. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res, 2000, 60:203-212.
2Tamm I, Dorken B, Hartmann G. Antisense therapy in oncology: new hope for an old idea? Lancet, 2001, 358:489-497.
3Pidgeon GP, Barr MP, Harmey JH, et al. Vascular endothelial growth factor (VEGF) upregulates Bcl-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer, 2001,85:273-278.
4Von Marschall Z, Cramer T, Hocker M, et al. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. Gastroenterology, 2000, 119:1358-1372.
5Bouwman P,Philipsen S. Regulation of the activity of Spl-related transcription factors. Mol Cell Endocrinol, 2002,195 : 27-38.
6Black AR,Black JD,Azizkhan-clifford J. Spl and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol,2001,188,143-160.
7Li L,He SH,Sun JM,et al. Gene regulation by Spl and Sp3. Biochem Cell Biol,2004,82:460- 471.
8Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer,2005,41: 2438-2448.
9Abdelrahim M,Smith R,Burghardt R,et al. Role of Sp protein in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res, 2004, 64: 6740-6749.
10Suske G. The Sp-family of transcription factors. Gene,1999, 238:291-300.